Paul Tudor Jones Revolution Medicines, Inc. Put Options Transaction History
Tudor Investment Corp Et Al
- $25.1 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding RVMD
# of Institutions
298Shares Held
168MCall Options Held
920KPut Options Held
1.06M-
Vanguard Group Inc Valley Forge, PA17.1MShares$651 Million0.01% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$511 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA13.2MShares$505 Million3.09% of portfolio
-
Janus Henderson Group PLC London, X09.48MShares$361 Million0.22% of portfolio
-
Baker Bros. Advisors LP New York, NY7.94MShares$302 Million3.85% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.34B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...